Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Great Ape Protection and Cost Savings Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Great Ape Protection and Cost Savings Act of 2011
Client: GENZYME · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SOLARCITY via PODESTA GROUP, INC.
2012 · third_quarter · 3A
Solar energy tax credits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KINDRED HEALTHCARE INC via PODESTA GROUP, INC.
2012 · first_quarter · 1A
Source: Senate LDA
| AMGEN |
| 23 |
| 2004–2012 |
| CHILDREN'S NATIONAL MEDICAL CENTER | 23 | 2006–2012 |
| CUBIST PHARMACEUTICALS, INC. | 23 | 2007–2012 |
| KINDRED HEALTHCARE INC | 18 | 2008–2012 |
| EISAI INC. | 17 | 2009–2012 |
| NOVARTIS SERVICES, INC. | 17 | 2008–2011 |
| ALLIANCE FOR QUALITY NURSING HOME CARE | 15 | 2007–2012 |
| COVIDIEN | 15 | 2007–2012 |
| GENENTECH | 15 | 2004–2009 |
| INTERNET2 | 12 | 2006–2009 |
| NATIONAL ASSOCIATION OF BROADCASTERS | 12 | 2007–2010 |
| XCALIBER INTERNATIONAL LTD, LLC | 12 | 2007–2009 |
| DOSAL TOBACCO COMPANY | 11 | 2007–2009 |
| NATIONAL TOBACCO | 11 | 2007–2009 |
| S & M BRANDS INC | 11 | 2007–2009 |
| SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT INC | 11 | 2009–2011 |
| WINNING STRATEGIES WASHINGTON LLC | 11 | 2009–2010 |
| UNIVERSAL AMERICAN CORPORATION | 10 | 2009–2011 |
| WAL-MART | 10 | 2009–2011 |
| CINTAS | 9 | 2007–2009 |
| PARTNERSHIP FOR QUALITY HOME HEALTHCARE | 9 | 2010–2012 |
| AKIN GUMP STRAUSS HAUER & FELD LLP | 8 | 2007–2009 |
| CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION | 8 | 2010–2012 |
| COUNCIL OF INDEPENDENT TOBACCO MANUFACTURERS ASSOCIATION | 8 | 2008–2009 |
| GENERAL DYNAMICS | 8 | 2007–2009 |
| LOCKHEED MARTIN CORPORATION | 8 | 2005–2011 |
| NATIONAL CONFECTIONERS ASSOCIATION | 7 | 2007–2010 |
| THE FORSYTH INSTITUTE | 7 | 2008–2009 |
| THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER | 7 | 2008–2009 |
| ALCATEL-LUCENT | 6 | 2007–2009 |
| HENRY SCHEIN INC | 6 | 2011 |
| MATTOON & ASSOCIATES, LLC | 6 | 2007–2008 |
| AMERICAN COALITION FOR CLEAN COAL ELECTRICITY | 5 | 2010–2011 |
| BLUE SHIELD OF CALIFORNIA | 5 | 2011 |
| CAREER EDUCATION CORPORATION | 5 | 2006–2008 |
| ENTERPRISE HOLDINGS | 5 | 2009–2011 |
| NETJETS INC | 5 | 2007–2008 |
| ORANGE COUNTY, FLORIDA | 5 | 2005–2006 |
| VITAL CARE, INC. | 5 | 2011 |
| AMERICAN MEAT INSTITUTE | 4 | 2010–2011 |
| CREEKSTONE FARMS PREMIUM BEEF | 4 | 2006–2007 |
| IDC OF KENTUCKY INCORPORATED | 4 | 2007–2008 |
| NATIONAL CHICKEN COUNCIL | 4 | 2010–2011 |
| NORVARTIS VACCINES & DIAGNOSTICS INC | 4 | 2006–2007 |
| PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA | 4 | 2004–2006 |
| UNIVERSITY OF PITTSBURGH MEDICAL CENTER | 4 | 2010–2011 |
| BETTER WORLD FUND | 3 | 2006–2007 |
| BIOTECHNOLOGY INDUSTRY ORGANIZATION | 3 | 2004 |
| CHIRON | 3 | 2004–2006 |
| GENERAL MOTORS COMPANY | 3 | 2010 |
| GOOGLE INC. | 3 | 2009–2010 |
| HOSPITAL PARTNERS | 3 | 2007–2008 |
| PFIZER, INC. | 3 | 2006–2007 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 3 | 2005–2006 |
| SCIENCE COALITION | 3 | 2006–2007 |
| SIGMA TAU PHARMACEUTICALS | 3 | 2004–2006 |
| SOLARCITY | 3 | 2012 |
| SYNTHETIC GENOMICS | 3 | 2010–2011 |
| TEXTRON INC. | 3 | 2007–2008 |
| THE J. DAVID GLADSTONE INSTITUTES | 3 | 2010–2011 |
| TJX COS INC | 3 | 2007–2008 |
| UNITED STATES HISPANIC CHAMBER OF COMMERCE | 3 | 2012 |
| AMERICAN CHEMISTRY COUNCIL | 2 | 2011–2012 |
| ASS'N OF PRIVATE SECTOR COLLEGES AND UNIVERSITIES (FKA CAREER COLLEGE ASS'N) | 2 | 2010–2011 |
| CAESARS ENTERTAINMENT OPERATING CO INC | 2 | 2012 |
| CHOCOLATE MANUFACTURES ASSOCIATION | 2 | 2007 |
| ECOSMART | 2 | 2007 |
| GLOBAL COMPUTER ENTERPRISES, INC. | 2 | 2010 |
| NATIONAL MINING ASSOCIATION | 2 | 2012 |
| NUTRITIONAL HEALTH ALLIANCE | 2 | 2004–2006 |
| PURESTREAM TECHNOLOGY, INC. | 2 | 2010 |
| VIRTUALSCOPICS | 2 | 2005 |
| VOYA SERVICES COMPANY | 2 | 2010–2011 |
| WARBURG PINCUS LLC | 2 | 2007 |
| ATKINS NUTRITIONALS | 1 | 2004 |
| Altria Group, Inc. | 1 | 2004 |
| BP AMERICA, INC. | 1 | 2007 |
| CHICKASAW ENTERPRISES | 1 | 2006 |
| DELOITTE LLP | 1 | 2011 |
| ELECTRIFICATION COALITION ALLIANCE | 1 | 2010 |
| FRIENDS OF THE EARTH | 1 | 2007 |
| INDEPENDENT FILM AND TELEVISION ALLIANCE | 1 | 2007 |
| INSTITUTE OF SCRAP RECYCLING INDUSTRIES, INC. | 1 | 2011 |
| NUTRITION 21 | 1 | 2005 |
| POLICY STUDIES, INC | 1 | 2009 |
| PROFESSIONAL SERVICES COUNCIL | 1 | 2011 |
| QUEST DIAGNOSTICS INCORPORATED | 1 | 2011 |
| SECURING AMERICA'S FUTURE ENERGY (SAFE) | 1 | 2010 |
| U S ONCOLOGY | 1 | 2005 |
| U.S. GREEN BUILDING COUNCIL | 1 | 2012 |
| US RENEWABLES GROUP | 1 | 2012 |
Great Ape Protection and Cost Savings Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Great Ape Protection and Cost Savings Act of 2011
Client: EISAI INC. · Firm: PODESTA GROUP, INC.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill).
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization.
Generating Antibiotic Incentives Now Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011.
Medicare Home Infusion Therapy Coverage Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Medicare Home Infusion Therapy Coverage Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Medicare Home Infusion Therapy Coverage Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Medicare Home Infusion Therapy Coverage Act of 2011
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H.R. 2954, The Health Equity and Accountability Act of 2011.
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
Health Equity and Accountability Act of 2011
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
H.R. 3522 / S. 965, Family Act of 2011.
H.R. 3522 / S. 965, Family Act of 2011.
H.R. 3522 / S. 965, Family Act of 2011.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Improper Payments Elimination and Recovery Improvement Act of 2012
Client: RELX INC · Firm: PODESTA GROUP, INC.
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Rural Hospital and Provider Equity and 340B Improvement Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: EISAI INC. · Firm: PODESTA GROUP, INC.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation.
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act "Track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: EISAI INC. · Firm: PODESTA GROUP, INC.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
Prescription Drug User Fee Act reauthorization. Biosimilar products. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill).
Prescription Drug User Fee Act reauthorization. Biosimilar products. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: BRISTOL-MYERS SQUIBB · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Food and Drug Administration Reform Act of 2012
Client: EISAI INC. · Firm: PODESTA GROUP, INC.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Prescription Drug User Fee Act reauthorization. Biosimilar products. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Food and Drug Administration Reform Act of 2012
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
Food and Drug Administration Reform Act of 2012
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Food and Drug Administration Reform Act of 2012
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
Food and Drug Administration Reform Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012.
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res. 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions - antibiotic resistance). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013 (Medicare-related provisions). H. J. Res. 117, Continuing Appropriations Resolution, 2013 (Medicare-related provisions).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: AMGEN · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: AMGEN · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: AMGEN · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: GENZYME · Firm: PODESTA GROUP, INC.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H.J. Res. 117, Continuing Appropriations Resolution, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: NOVO NORDISK INC · Firm: PODESTA GROUP, INC.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: GENZYME · Firm: PODESTA GROUP, INC.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
H. Con. Res. 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: GENZYME · Firm: PODESTA GROUP, INC.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H.J. Res. 117, Continuing Appropriations Resolution, 2013.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: MILLENNIUM PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
FY 2013 budget resolutions. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
FDA User Fee Corrections Act of 2012
Client: CUBIST PHARMACEUTICALS INC · Firm: PODESTA GROUP, INC.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012.
FDA User Fee Corrections Act of 2012
Client: BRISTOL-MYERS SQUIBB · Firm: PODESTA GROUP, INC.
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. H.R. 6433, FDA User Fee Corrections Act of 2012.
Prescription Drug User Fee Act reauthorization. Biosimilar products. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. H.R. 6433, FDA User Fee Corrections Act of 2012.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
Prescription Drug User Fee Act reauthorization. Biosimilar products. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. H.R. 6433, FDA User Fee Corrections Act of 2012.
Medicare Part B therapy services. Regulation of long-term acute care hospitals. Independent rehabilitation facilities. CMS proposed rule changes.H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. S. 1486, Long-Term Care Hospital Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO INC via PODESTA GROUP, INC.
2012 · third_quarter · 3A
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. H.R. 6433, FDA User Fee Corrections Act of 2012.
H.R. 3522 / S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
NATIONAL MINING ASSOCIATION via PODESTA GROUP, INC.
2012 · fourth_quarter · 4@
Promoting coal exports.
Filing targets: Army, Dept of (Corps of Engineers), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
RELX INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Diabetes screening. Diabetes-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 (implementation). Medicaid rebates. 340B changes. S. 3463, Medicare Diabetes Prevention Act of 2012. H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
NATIONAL MINING ASSOCIATION via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Promoting coal exports.
Filing targets: Army, Dept of (Corps of Engineers), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
H. Con. Res. 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
GENZYME via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
340B issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
EMD SERONO INC via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
H.R. 3522 / S. 965, Family Act of 2011.
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. H.R. 6433, FDA User Fee Corrections Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care. H.R. 6597 / S. 3695, EACH Act.
Issues related to the coverage of spiritual care. H.R. 6597 / S. 3695, EACH Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S NATIONAL MEDICAL CENTER via PODESTA GROUP, INC.
2012 · fourth_quarter · Q4
Funding for Children's Hospitals Graduate Medical Education program. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. Medicaid funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2012 · fourth_quarter · 4T
Medicare coverage and reimbursement issues. Diabetes issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
2012 · fourth_quarter · Q4
Prescription Drug User Fee Act reauthorization. Biosimilar products. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Medicare Part B reimbursement and coverage of dialysis products.
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · third_quarter · 3A
Diabetes screening. Diabetes-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 (implementation). Medicaid rebates. 340B changes. S. 3463, Medicare Diabetes Prevention Act of 2012.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
RELX INC via PODESTA GROUP, INC.
2012 · third_quarter · 3A
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SOLARCITY via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Solar energy tax credits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RELX INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
GENZYME via PODESTA GROUP, INC.
2012 · third_quarter · Q3
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H.J. Res. 117, Continuing Appropriations Resolution, 2013.
340B issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
EMD SERONO INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. H.R. 6433, FDA User Fee Corrections Act of 2012.
H.R. 3522 / S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Student Loan Auction Rate Securities (SLARS)
Student Loan Auction Rate Securities (SLARS).
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012. H.R. 6433, FDA User Fee Corrections Act of 2012.
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Issues related to the coverage of spiritual care.
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S NATIONAL MEDICAL CENTER via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Funding for Children's Hospitals Graduate Medical Education program. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. Medicaid funding.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
CAESARS ENTERTAINMENT OPERATING CO INC via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Legislation to license and regulate online poker. Unlawful Internet Gambling Enforcement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2012 · third_quarter · Q3
Medicare coverage and reimbursement issues. Diabetes issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes research issues.
2012 · third_quarter · Q3
Medicare Part B reimbursement and coverage of dialysis products.
Prescription Drug User Fee Act reauthorization. Biosimilar products. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
UNITED STATES HISPANIC CHAMBER OF COMMERCE via PODESTA GROUP, INC.
2012 · first_quarter · 1A
General small business issues. Access to capital.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
UNITED STATES HISPANIC CHAMBER OF COMMERCE via PODESTA GROUP, INC.
2012 · first_quarter · Q1
General small business issues. Access to capital.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
SOLARCITY via PODESTA GROUP, INC.
2012 · third_quarter · RR
Solar energy tax credits.
Solar energy tax credits.
RELX INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Health IT issues; waste, fraud, and abuse issues. H.R. 3399 / S. 1251, Medicare and Medicaid FAST Act of 2011. H.R. 4053 / S. 1409, Improper Payments Elimination and Recovery Improvement Act of 2012.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. Independent Payment Advisory Board legislation.
Fertility tax credits. Foreign taxation issues. S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill).
COVIDIEN via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S NATIONAL MEDICAL CENTER via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Funding for Children's Hospitals Graduate Medical Education program. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAESARS ENTERTAINMENT OPERATING CO INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Legislation to license and regulate online poker. Unlawful Internet Gambling Enforcement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR QUALITY NURSING HOME CARE via PODESTA GROUP, INC.
2012 · second_quarter · Q2
CMS regulation. Medicare and Medicaid reform. Skilled nursing facility funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act.
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Issues related to coverage of spiritual care. TRICARE coverage of spiritual care.
Issues related to the coverage of spiritual care.
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GENZYME via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
340B issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
EISAI INC. via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Student Loan Auction Rate Securities (SLARS)
Student Loan Auction Rate Securities (SLARS).
Branded prescription pharmaceutical fee under health care reform.
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2012 · second_quarter · Q2
Diabetes issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Medicare coverage and reimbursement issues. Diabetes issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act "Track and trace" issues.
2012 · second_quarter · Q2
Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Medicare Part B reimbursement and coverage of dialysis products.
Prescription Drug User Fee Act reauthorization. Biosimilar products. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
U.S. GREEN BUILDING COUNCIL via PODESTA GROUP, INC.
2012 · first_quarter · Q1
White House Better Building Initiative; tax and other provisions to promote investment in more efficient commercial buildings.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
US RENEWABLES GROUP via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Renewable energy tax credit extensions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO INC via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. Independent Payment Advisory Board legislation. S. 425, National Neurological Diseases Surveillance System Act of 2011
Fertility tax credits. Foreign taxation issues. S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES HISPANIC CHAMBER OF COMMERCE via PODESTA GROUP, INC.
2012 · first_quarter · Q1
General small business issues. Access to capital.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
CHILDREN'S NATIONAL MEDICAL CENTER via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Funding for Children's Hospitals Graduate Medical Education program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL via PODESTA GROUP, INC.
2012 · first_quarter · Q1
S. 1863, New Alternative Transportation to Give Americans Solutions Act of 2011. S. 1813, MAP-21 (transportation reauthorization).
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
ALLIANCE FOR QUALITY NURSING HOME CARE via PODESTA GROUP, INC.
2012 · first_quarter · Q1
CMS regulation. Medicare and Medicaid reform. Skilled nursing facility funding. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions).
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
NOVO NORDISK INC via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Diabetes-related issues.
H.R. 2954, The Health Equity and Accountability Act of 2011.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
GENZYME via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). Product exclusivity issues.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Medicare issues related to end stage renal disease. Medicare reimbursement issues. ASP changes; 340B issues.
FY 2013 budget appropriations. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Medicare coverage and reimbursement issues. Diabetes issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes research issues.
Diabetes issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
2012 · first_quarter · Q1
Prescription Drug User Fee Act reauthorization. Biosimilar products.
Prescription Drug User Fee Act reauthorization. FY 2013 funding regarding the FDA.
Medicare Part B reimbursement and coverage of dialysis products.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, State, Dept of (DOS)
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2012 · first_quarter · Q1
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
FY 2013 budget resolutions. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
KINDRED HEALTHCARE INC via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Medicare Part B therapy services. Regulation of long-term acute care hospitals. Independent rehabilitation facilities. CMS proposed rule changes. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. S. 1486, Long-Term Care Hospital Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI INC. via PODESTA GROUP, INC.
2012 · first_quarter · Q1
Student Loan Auction Rate Securities (SLARS)
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Branded prescription pharmaceutical fee under health care reform.
SYNTHETIC GENOMICS via PODESTA GROUP, INC.
2011 · fourth_quarter · 4A
Legislation and regulation regarding next generation biofuels. Formation of Synthetic Biology Caucus.
Filing targets: HOUSE OF REPRESENTATIVES
LOCKHEED MARTIN CORPORATION via PODESTA GROUP, INC.
2011 · second_quarter · 2A
Issues pertaining to general defense and defense appropriations. H.R. 2219, FY 2012 Department of Defense appropriations. H.R. 1540, National Defense Authorization Act for Fiscal Year 2012.
Filing targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
VITAL CARE, INC. via PODESTA GROUP, INC.
2011 · third_quarter · 3A
CMS payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
ENTERPRISE HOLDINGS via PODESTA GROUP, INC.
2011 · second_quarter · 2A
Surface Transportation reauthorization. H.R. 658, FAA Reauthorization and Reform Act of 2011. S. 223, FAA Air Transportation Modernization and Safety Improvement Act. End Discriminatory State Taxes for Automobile Renters Act. Rental car recall legislation. Tort reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
HENRY SCHEIN, INC. via PODESTA GROUP, INC.
2011 · fourth_quarter · 4@
Advocacy related to distribution contracts for federal vaccine programs. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012 S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012.
Advocacy related to distribution contracts for federal vaccine programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYNTHETIC GENOMICS via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Legislation and regulation regarding next generation biofuels. Formation of Synthetic Biology Caucus.
Filing targets: HOUSE OF REPRESENTATIVES
SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT, INC. via PODESTA GROUP, INC.
2011 · fourth_quarter · 4T
Patient Protection and Affordable Care Act implementation. Medicare and Medicaid funding. S. 1486, Long-Term Care Hospital Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WAL-MART via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Health care legislative reform: policy options, financing policy options, delivery system reform options, employer responsibility.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues. H.R. 3630, Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Diabetes-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
FY 2012 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
HENRY SCHEIN, INC. via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Advocacy related to distribution contracts for federal vaccine programs.
Advocacy related to distribution contracts for federal vaccine programs. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012 S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011.
EMD SERONO INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Fertility tax credits. Foreign taxation issues. S. 965, Family Act of 2011.
Patient Protection and Affordable Care Act implementation. Prescription Drug User Fee Act reauthorization. Independent Payment Advisory Board legislation. S. 425, National Neurological Diseases Surveillance System Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHRISTIAN SCIENCE COMMITTEE ON PUBLICATION via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Issues related to the coverage of spiritual care.
Issues related to coverage of spiritual care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), SENATE
CHILDREN'S NATIONAL MEDICAL CENTER via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Funding for Children's Hospital Graduate Medical Education program. Medicaid funding. HHS grant programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE SHIELD OF CALIFORNIA via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Legislation and regulations affecting health plans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CHEMISTRY COUNCIL via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Legislative and regulatory issues related to HHS and EPA chemical reports and assessments. S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012. Chemical facility anti-terrorism standards.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR QUALITY NURSING HOME CARE via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
CMS regulation. Medicare and Medicaid reform. Skilled nursing facility funding. H.R. 3630, Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COALITION FOR CLEAN COAL ELECTRICITY via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
H.R. 2273 / S. 1751, Coal Residuals Reuse and Management Act of 2011 H.R. 2401, Transparency in Regulatory Analysis of Impacts on the Nation Act of 2011 H.R. 2584, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2012 S. 609, Comprehensive Assessment of Regulations on the Economy Act of 2011 S. 1833, Fair Compliance Act of 2011.
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Treasury, Dept of
MILLENNIUM PHARMACEUTICALS INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
GENZYME via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
FY 2012 budget appropriations. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Medicare issues related to end stage renal disease. ASP changes. 340B issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Medicare reimbursement issues.
KINDRED HEALTHCARE INC via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Medicare Part B therapy services. Regulation of long-term acute care hospitals. Independent rehabilitation facilities. CMS proposed rule changes. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. S. 1486 Long-Term Care Hospital Improvement Act of 2011.
Medicare Part B therapy services. Regulation of long term acute care hospitals; education and development of new legislation for LTAC patient & facility criteria. Independent rehabilitiation facilities. CMS proposed rule changes. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. S. 1486 Long-Term Care Hospital Improvement Act of 2011.
BRISTOL-MYERS SQUIBB via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Prescription Drug User Fee Act reauthorization. FDA issues. Diabetes drugs issues. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Diabetes issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
EISAI INC. via PODESTA GROUP, INC.
2011 · fourth_quarter · Q4
Student Loan Auction Rate Securities (SLARS). H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Medicare coverage and reimbursement issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
2011 · fourth_quarter · Q4
Medicare Part B reimbursement and coverage of dialysis products. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Prescription Drug User Fee Act reauthorization. FY 2011 funding regarding the FDA. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012.
VITAL CARE, INC. via PODESTA GROUP, INC.
2011 · third_quarter · 3A
CMS payment policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Supporting university medical center government relations.
SPARTANBURG REGIONAL HEALTH SERVICES DISTRICT, INC. via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Patient Protection and Affordable Care Act implementation. Medicare and Medicaid reform, generally. S. 1486, Long-Term Care Hospital Improvement Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PODESTA GROUP, INC.
2011 · third_quarter · Q3
Center for Medicare and Medicaid Services proposed rules. Payment for home health services. Program integrity issues. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC via PODESTA GROUP, INC.
2011 · third_quarter · Q3
H.R. 1249/S. 23, America Invents Act.
FY 2012 Budget Resolutions (diabetes-related issues). S. 1599, FY 2012 Labor-HHS Appropriations. H.R. 2112, FY 2012 Agriculture Appropriations. National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation.
Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H.J. Res. 117, Continuing Appropriations Resolution, 2013.
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Medicare issues related to end stage renal disease. Medicare reimbursement issues. ASP changes; 340B issues. H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Student Loan Auction Rate Securities (SLARS).
Student Loan Auction Rate Securities (SLARS).
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions - antibiotic resistance). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013 (Medicare-related provisions). H. J. Res. 117, Continuing Appropriations Resolution, 2013 (Medicare-related provisions).
Medicare home infusion and reimbursement issues. 340B drug pricing program issues, including program expansion. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes research issues.
Diabetes issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
H.R. 2954, The Health Equity and Accountability Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6482, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Diabetes screening. Diabetes-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 (implementation). Medicaid rebates. 340B changes. S. 3463, Medicare Diabetes Prevention Act of 2012.
Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res. 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Medicare issues related to end stage renal disease. Medicare reimbursement issues. ASP changes; 340B issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Diabetes drugs issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "Track and trace" issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. Prescription Drug User Fee Act reauthorization. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012.
Medicare home infusion and reimbursement issues. 340B issues. H.R. 2195 / S. 1203, Medicare Home Infusion Therapy Coverage Act of 2011. H. Con. Res 112, Establishing the budget for the US Government for FY 2013 (Medicare-related provisions). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5194, Rural Hospital and Provider Equity and 340B Improvement Act of 2012. H.R. 5624, Rural Hospital and Provider Equity and 340B Improvement Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Diabetes-related issues.
FY 2013 Budget Resolutions (diabetes-related issues). National Diabetes Prevention Program; diabetes-related issues and cost estimate legislation. S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013. 2013 Labor-HHS Appropriations (House) (no bill). H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Diabetes screening. Diabetes-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 (implementation). Medicaid rebates. 340B changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
FY 2013 budget resolutions. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 5973 / S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Medicare issues related to end stage renal disease. Medicare reimbursement issues. ASP changes; 340B issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation.
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Diabetes research issues.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Medical research. Antibiotic resistance issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation.
Diabetes screening. Diabetes-related issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 (implementation). Medicaid rebates. 340B changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B issues Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. FDA issues. Diabetes drugs issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Student Loan Auction Rate Securities (SLARS).
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding minority health, diabetes screening, National Diabetes Prevention Program. H.R. 2954, The Health Equity and Accountability Act of 2011. H.R. 2960, National Diabetes Clinical Care Commission Act. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Diabetes screening. Diabetes-related issues. H.R. 2741, Preventing Diabetes in Medicare Act of 2011. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 implementation. Medicaid rebates. ASP changes. 340B changes.
Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Antibiotic resistance issues. Pay-for-delay proposals and generic issues. H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act of 2011. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). Product exclusivity issues.
340B issues Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare coverage and reimbursement issues. Diabetes issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Diabetes research issues. H.R. 3070 / S. 1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Alzheimer's issues. Breast cancer efforts. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Student Loan Auction Rate Securities (SLARS) H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Drug issues. Prescription Drug User Fee Act reauthorization. FDA-DEA issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescription Drug User Fee Act reauthorization. Biosimilar products.
Filing targets: Council of Economic Advisers (CEA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding minority health, diabetes screening, National Diabetes Prevention Program. H.R. 2954, The Health Equity and Accountability Act of 2011. H.R. 2960, National Diabetes Clinical Care Commission Act. S. 1599, FY 2012 Labor-HHS Appropriations.
Diabetes screening. Diabetes-related issues. H.R. 2741, Preventing Diabetes in Medicare Act of 2011. Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act implementation. Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010 implementation. Medicaid rebates. ASP changes. 340B changes.
Diabetes-related issues.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE